Journal article
The DIalysis Symptom COntrol-Restless Legs Syndrome (DISCO-RLS) Trial: A Protocol for a Randomized, Crossover, Placebo-Controlled Blinded Trial
Abstract
BACKGROUND: Restless legs syndrome (RLS) affects approximately 30% of patients with end-stage kidney disease and is associated with impaired sleep and health-related quality of life. Medications used to treat RLS in patients receiving dialysis may have an increased risk of adverse events with dose titration, and residual RLS symptoms are common despite the use of effective treatments. Randomized controlled trials of monotherapy and combination …
Authors
Collister D; Pohl K; Herrington G; Lee SF; Rabbat C; Tennankore K; Zimmermann D; Tangri N; Wald R; Manns B
Journal
Canadian Journal of Kidney Health and Disease, Vol. 7, ,
Publisher
SAGE Publications
Publication Date
January 2020
DOI
10.1177/2054358120968959
ISSN
2054-3581